NEW YORK--(BUSINESS WIRE)--OS Therapies, Inc. (NYSE-A ... the Innovative Licensing and Access Pathway (ILAP) with the United Kingdom’s (UK) Medicines and Healthcare products Regulatory Agency ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback